04:29 AM EDT, 06/26/2024 (MT Newswires) -- Taysha Gene Therapies ( TSHA ) said late Tuesday it has started an up to $75 million offering of its shares and pre-funded warrants.

The company said it will sell all the securities in the underwritten public offering.

It intends to grant underwriters a 30-day option to purchase up to an additional 15% of shares in the offering.

Taysha Gene shares were down 10.8% in premarket activity Wednesday.

Price: 2.1800, Change: -0.28, Percent Change: -10.75